NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

We could also say that UCLA has no rights to DCVAX. What does it matter? The value is in the manufacturing. The product is the same. UCLA is not developing the manufacturing or commercialization to mass produce ATL DC. NWBO is developing the infrastructure to commercialize it. UCLA is just going to help prove it works, just like any other research site. They’re in the business of treating patients. NWBO is in the business of producing vaccine. It’s a shame that a health science reporter wouldn’t know the difference in these business models.